If you experience chronic pain and PTSD, you might find yourself stuck in a loop of unhelpful thinking and avoidance behaviors that backfire over time. Research shows that people with both chronic ...

New York, April 02, 2025 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) invites the public to a free webinar, “Developing a Potential New Treatment for Chronic PTSD: Ketamine ...

NEW YORK (Reuters Health) - Post-traumatic stress disorder (PTSD) is more common in people who suffer from chronic migraine headache than in those with episodic migraine headache, research suggests.

A new study led by researchers from Murdoch University's School of Psychology, Personalized Medicine Center, and Center for Healthy Aging, Health Futures Institute has found that heart rate ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...

A Louisiana House committee voted Thursday (April 5) in favor of a proposal to expand the use of medical marijuana to treat people with chronic pain, post-traumatic stress disorder and glaucoma. The ...

February 3, 2025 – Two major new studies from the Columbia University Mailman School of Public Health reveal that veterans of the Vietnam War continue to face significant psychological and physical ...

Developing Therapeutics for the Treatment of CNS Disorders, Specifically Suicidal Bipolar Depression, Chronic Pain and PTSD. Incorporation of HOPE Therapeutics Dedicated to NRX-100 (IV Ketamine) for ...

They fight for our freedoms but often struggle to live their own lives freely due to post-traumatic stress disorder (PTSD). Roughly 7% of all US service veterans have PTSD, with symptoms such as ...

Synthetically altered products that mimic intoxication should absolutely be regulated or restricted, but as currently drafted, this language goes much further than that by essentially banning ...

RTI International launched a randomized, controlled trial of SGB in 2014 and concluded in 2019 that the treatment "is indeed ...